Having trouble accessing articles? Reset your cache.

Allergan buys gene therapy play RetroSense

Allergan plc (NYSE:AGN) acquired RetroSense Therapeutics LLC (Ann Arbor, Mich.), giving it retinitis pigmentosa (RP) candidate RST-001.

Read the full 172 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE